discipline summaries
supervisor(s) for review and approval prior
to prescribing narcotics or restricted substances to the patient. Thereafter, Dr. Reid
shall submit these patients’ charts including
documentation of the prescriptions and the
narcotics log to the clinical supervisor(s)
for review and meet with the clinical
supervisor(s) every two weeks to discuss the
care of these patients and any concerns that
the clinical supervisor(s) may have.
(iii) If reports from the clinical supervisor(s)
indicate that it is appropriate to do so
and if approved by the College, after a
minimum of three months in Phase One
of the remediation program, Dr. Reid may
commence Phase Two of the remediation
program, during which he shall prescribe
narcotics or restricted Substances to no
more than 40 patients, whose charts shall be
reviewed at least once a month by his clinical supervisor(s) together with the narcotics
log. During Phase Two of the remediation
program, Dr. Reid shall meet with his clinical supervisor(s) once a month to discuss the
care of these patients and any concerns that
the clinical supervisor(s) may have.
(iv) If reports from the clinical supervisor(s)
indicate that it is appropriate to do so and
if approved by the College, after a minimum of three months in Phase Two of
the remediation program, Dr. Reid may
commence Phase Three of the remediation program, which shall include monthly
review by the clinical supervisor(s) of at
least 20 charts of patients to whom Dr.
Reid prescribes narcotics or restricted
substances, to be randomly selected by the
clinical supervisor(s), and monthly review
of the narcotics log.
(v) If reports from the clinical supervisor(s) indicate that it is appropriate to do so and if
approved by the College, after a minimum
of six months in Phase Three of the remediation program, Dr. Reid may complete
the remediation program, but shall continue to maintain a narcotics log pending
completion of the assessment described at
paragraph (g), below.
(vi) Throughout the remediation program,
Dr. Reid shall cooperate with the clinical
supervisor(s) and shall abide by the recommendations of his clinical supervisor(s),
including with respect to patient care,
practice management, and continuing
education.
(g) D
r. Reid shall undergo an assessment by a
College-appointed assessor(s) approximately 12
months after the conclusion of the remediation
program, focusing on patients to whom Dr.
Reid prescribes narcotics or restricted substances. The assessment may include, but need
not be limited to, review of charts, interview(s),
and observation. The assessor(s) shall report
the results of the assessment to the College.
Dr. Reid shall cooperate with the assessment
and shall abide by the recommendations of the
assessor(s).
(h) D
r. Reid shall consent to the sharing of information among the assessor(s), clinical
supervisor(s) and the College as any of them
deem necessary or desirable in order to fulfill
their respective obligations.
(i) D
r. Reid shall not post-date prescriptions for
narcotics or restricted substances.
(j) D
r. Reid shall cooperate with unannounced
inspections of his practice and patient charts by
the College for the purpose of monitoring and
enforcing his compliance with the terms of this
Order and shall consent to the College making
appropriate enquiries of the Ontario Health
Insurance Plan, Narcotics Monitoring System
and/or Ontario Drug Benefit Program, and/or
any person or institution who may have relevant
information for this purpose.
(k) D
r. Reid shall be responsible for any and all
costs associated with implementing the terms of
this Order.
4. Dr. Reid pay the College its costs of this proceeding
in the amount of $4,460 within 60 days of the date of
this Order.
At the conclusion of the hearing, Dr. Reid waived his right
to an appeal and the Committee administered the public
reprimand.
Issue 3, 2015 Dialogue
63